rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5-6
|
pubmed:dateCreated |
1996-4-4
|
pubmed:abstractText |
A patient with high fever, loss of weight and profound pancytopenia is reported. Peripheral T-cell lymphoma with hemophagocytosis was diagnosed. Bone marrow was the only localisation of the lymphoma. At presentation there were (i) a coagulopathy consistent with hemophagocytic histiocytosis (ii) the features of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). These different abnormalities disappeared after chemotherapy and reappeared during each of the 2 periods of disease progression. The patient died 6 months after diagnosis without ever achieving complete remission. As far as we are aware this is the first case report of T-cell lymphoma with hemophagocytic syndrome localised to the bone marrow and associated with SIADH.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bleomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Mitoguazone,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Teniposide,
http://linkedlifedata.com/resource/pubmed/chemical/Verapamil,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine,
http://linkedlifedata.com/resource/pubmed/chemical/Vindesine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1042-8194
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
511-4
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:8590855-Aged,
pubmed-meshheading:8590855-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8590855-Bleomycin,
pubmed-meshheading:8590855-Bone Marrow Diseases,
pubmed-meshheading:8590855-Cisplatin,
pubmed-meshheading:8590855-Cyclophosphamide,
pubmed-meshheading:8590855-Cytarabine,
pubmed-meshheading:8590855-Dexamethasone,
pubmed-meshheading:8590855-Disease Progression,
pubmed-meshheading:8590855-Doxorubicin,
pubmed-meshheading:8590855-Fatal Outcome,
pubmed-meshheading:8590855-Female,
pubmed-meshheading:8590855-Histiocytosis, Non-Langerhans-Cell,
pubmed-meshheading:8590855-Humans,
pubmed-meshheading:8590855-Ifosfamide,
pubmed-meshheading:8590855-Inappropriate ADH Syndrome,
pubmed-meshheading:8590855-Lymphoma, T-Cell, Peripheral,
pubmed-meshheading:8590855-Methotrexate,
pubmed-meshheading:8590855-Mitoguazone,
pubmed-meshheading:8590855-Prednisone,
pubmed-meshheading:8590855-Teniposide,
pubmed-meshheading:8590855-Verapamil,
pubmed-meshheading:8590855-Vincristine,
pubmed-meshheading:8590855-Vindesine
|
pubmed:year |
1995
|
pubmed:articleTitle |
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
|
pubmed:affiliation |
Laboratoire Central d'Hématologie, Hôpital Hôtel-Dieu, Paris, France.
|
pubmed:publicationType |
Journal Article,
Case Reports
|